Strem Brian M. 4
4 · KIORA PHARMACEUTICALS INC · Filed Jul 3, 2024
Insider Transaction Report
Form 4
Strem Brian M.
DirectorPresident and CEO
Transactions
- Award
Common Stock
2024-07-01+15,629→ 30,160 total - Award
Stock Option (right to buy)
2024-07-01+31,259→ 31,259 totalExercise: $4.35From: 2025-07-01Exp: 2034-07-01→ Common Stock (31,259 underlying)
Footnotes (2)
- [F1]Grant of restricted stock from the Issuer pursuant to the Issuer's 2024 Equity Incentive Plan (the "Plan"). The restrictions will vest as to one-third (1/3) of the shares on each of July 1, 2025, July 1, 2026 and July 1, 2027, subject to the reporting person's continuous service through each such vesting date.
- [F2]The reporting person received an option to purchase Common Stock from the Issuer pursuant to the Plan. The option will become exercisable as to one-third (1/3) of the shares underlying the Option on July 1, 2025, and the remaining balance vests monthly on the first day of each calendar month thereafter for a period of two years, subject to the reporting person's continuous service through each such vesting date.